Comparative efficacy and safety of B-TUVP vs. B-TURP for benign prostatic hyperplasia at a tertiary centre in eastern Nepal
Abstract
Introduction: Bipolar transurethral resection of the prostate (B-TURP) is an established surgical treatment for benign prostatic hyperplasia (BPH). Bipolar transurethral vaporization (B-TUVP) of the prostate using a button electrode has emerged as an alternative with potential safety advantages. This study compared the efficacy and safety of B-TUVP versus B-TURP in a tertiary centre in eastern Nepal.
Methods: A retrospective cohort study of BPH treated between Jan 2021 and Dec 2024 at B and C Medical College and Teaching Hospital, Birtamod, Nepal, was conducted. Ethical approval was obtained. Patients were categorized into B-TUVP and B-TURP groups. Variables included operative time, irrigation time, haemoglobin drop, hospital stay, catheterization duration, IPSS, Qmax, QOL, and PVRV. Follow-up was at 4, 8, 12, and 24 months. Data analysis was done by SPSS version 29. A p≤0.05 was considered significant.
Results: A total of 400 patients (B-TUVP n=200, B-TURP n=200) were included. Baseline characteristics were comparable between groups. B-TUVP had longer operative time (60.94±18.64 vs 49.85±9.35 min, p=0.001) but shorter postoperative irrigation time (11.03±0.82 vs 14.99±2.02 h, p=0.001), less haemoglobin drop (0.74±0.14 vs 0.99±0.11 g/dL, p=0.001), shorter hospital stay (2.93±0.83 vs 3.50±1.10 days, p=0.001) and catheterization duration (3.03±0.84 vs 3.99±1.35 days, p=0.001). IPSS and Qmax improved significantly in both groups, with B-TURP showing better early outcomes.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 400 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.